
Christina Bradley
Examiner (ID: 15421, Phone: (571)272-9044 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1515 |
| Issued Applications | 846 |
| Pending Applications | 168 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11762254
[patent_doc_number] => 09370547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'Compositions and methods for treating ischemia'
[patent_app_type] => utility
[patent_app_number] => 14/620013
[patent_app_country] => US
[patent_app_date] => 2015-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 8111
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14620013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/620013 | Compositions and methods for treating ischemia | Feb 10, 2015 | Issued |
Array
(
[id] => 10654746
[patent_doc_number] => 20160000889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/613882
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 94
[patent_figures_cnt] => 94
[patent_no_of_words] => 43417
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14613882
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/613882 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES | Feb 3, 2015 | Abandoned |
Array
(
[id] => 11381558
[patent_doc_number] => 20170007615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'Antibacterial Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/116150
[patent_app_country] => US
[patent_app_date] => 2015-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 54378
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15116150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/116150 | Antibacterial Compounds | Feb 2, 2015 | Abandoned |
Array
(
[id] => 10263302
[patent_doc_number] => 20150148299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'TOPICAL FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/611993
[patent_app_country] => US
[patent_app_date] => 2015-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16374
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14611993
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/611993 | TOPICAL FORMULATIONS AND USES THEREOF | Feb 1, 2015 | Abandoned |
| 14/610499 | PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS | Jan 29, 2015 | Abandoned |
Array
(
[id] => 13165625
[patent_doc_number] => 10098904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Zidovudine combination therapies for treating microbial infections
[patent_app_type] => utility
[patent_app_number] => 15/111275
[patent_app_country] => US
[patent_app_date] => 2015-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 48
[patent_no_of_words] => 11929
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111275
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/111275 | Zidovudine combination therapies for treating microbial infections | Jan 28, 2015 | Issued |
Array
(
[id] => 11311978
[patent_doc_number] => 20160348088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'Colistin Synthetases and Corresponding Gene Cluster'
[patent_app_type] => utility
[patent_app_number] => 15/113978
[patent_app_country] => US
[patent_app_date] => 2015-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9109
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113978 | Colistin synthetases and corresponding gene cluster | Jan 25, 2015 | Issued |
Array
(
[id] => 12191704
[patent_doc_number] => 09895419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Goblet cell replacement therapy'
[patent_app_type] => utility
[patent_app_number] => 15/113035
[patent_app_country] => US
[patent_app_date] => 2015-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 10476
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113035 | Goblet cell replacement therapy | Jan 19, 2015 | Issued |
Array
(
[id] => 10312543
[patent_doc_number] => 20150197545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'SYNTHETIC PEPTIDE AMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/585438
[patent_app_country] => US
[patent_app_date] => 2014-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 38070
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14585438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/585438 | Synthetic peptide amides | Dec 29, 2014 | Issued |
Array
(
[id] => 10220324
[patent_doc_number] => 20150105318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'ANTIDIABETIC MEDICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/578552
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26196
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14578552
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/578552 | ANTIDIABETIC MEDICATIONS | Dec 21, 2014 | Abandoned |
Array
(
[id] => 11122310
[patent_doc_number] => 20160319284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLIEC ACID-BASED AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/104701
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23823
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104701 | Methods and compositions for treating cancer using peptide nucleic acid-based agents | Dec 16, 2014 | Issued |
Array
(
[id] => 10290612
[patent_doc_number] => 20150175612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'CRYSTAL FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/559101
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7904
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14559101
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/559101 | CRYSTAL FORMS | Dec 2, 2014 | Abandoned |
Array
(
[id] => 10267142
[patent_doc_number] => 20150152138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'USES OF KAPPA OPIOID SYNTHETIC PEPTIDE AMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/557576
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47658
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14557576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/557576 | Uses of kappa opioid synthetic peptide amides | Dec 1, 2014 | Issued |
Array
(
[id] => 10209276
[patent_doc_number] => 20150094265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'Treatments for Gastrointestinal Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/556573
[patent_app_country] => US
[patent_app_date] => 2014-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12108
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14556573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/556573 | Treatments for Gastrointestinal Disorders | Nov 30, 2014 | Abandoned |
Array
(
[id] => 15912787
[patent_doc_number] => 10653613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue
[patent_app_type] => utility
[patent_app_number] => 15/104813
[patent_app_country] => US
[patent_app_date] => 2014-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 5605
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104813
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104813 | Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue | Nov 27, 2014 | Issued |
Array
(
[id] => 12445470
[patent_doc_number] => 09981003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => CXCR antagonistic peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/038557
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30702
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038557 | CXCR antagonistic peptides and uses thereof | Nov 24, 2014 | Issued |
Array
(
[id] => 10298829
[patent_doc_number] => 20150183828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/552555
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 38512
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552555
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/552555 | Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof | Nov 24, 2014 | Abandoned |
Array
(
[id] => 12945619
[patent_doc_number] => 09834579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Crystalline forms of s-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations
[patent_app_type] => utility
[patent_app_number] => 15/034806
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 3965
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034806
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034806 | Crystalline forms of s-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations | Nov 5, 2014 | Issued |
Array
(
[id] => 10241463
[patent_doc_number] => 20150126458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN'
[patent_app_type] => utility
[patent_app_number] => 14/532397
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18061
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14532397
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/532397 | METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN | Nov 3, 2014 | Abandoned |
Array
(
[id] => 11077145
[patent_doc_number] => 20160274108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/031941
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 39383
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031941 | DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY | Oct 23, 2014 | Abandoned |